dermovate 0.5 mg/ ml
2care4 aps - klobetasolpropionat - oppløsning - 0.5 mg/ ml
dermovat 0.05 %
2care4 aps - klobetasolpropionat - salve - 0.05 %
nasonex 50 mikrog/ dose
farmagon - mometasonfuroat - nesespray, suspensjon - 50 mikrog/ dose
nasonex 50 mikrog/ dose
farmagon - mometasonfuroat - nesespray, suspensjon - 50 mikrog/ dose
elocom 0.1 %
orifarm as - mometasonfuroat - liniment, oppløsning - 0.1 %
toradol 30 mg/ ml
atnahs pharma netherlands b.v. - ketorolaktrometamol - injeksjonsvæske, oppløsning - 30 mg/ ml
toradol 30 mg/ ml
2care4 aps - ketorolaktrometamol - injeksjonsvæske, oppløsning - 30 mg/ ml
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - legemidler for obstruktive sykdommer i luftveiene, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - legemidler for obstruktive sykdommer i luftveiene, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - legemidler for obstruktive sykdommer i luftveiene, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.